Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[A Case of Tubular Carcinoma of the Breast]Hitomi Kubota, Kenichi Sakurai, Shuhei Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[A Case of Thyroid Cancer Discovered Incidentally after Breast Cancer Surgery]Kenichi Sakurai, Shuhei Suzuki, Keita Adachi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[Pleomorphic Invasive Lobular Carcinoma Developed after Surgery for Simultaneous Ipsilateral Multiple Cancers]Kenichi Sakurai, Shuhei Suzuki, Keita Adachi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Indoleamine 2,3-Dioxygenase Activity during Letrozol Therapy for an Elderly Breast Cancer Patient]Kenichi Sakurai, Shigeru Fujisaki, Hitomi Kubota, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Clinical Evaluation of Indoleamine 2, 3-Dioxygenase in the Serum of Patients with Locally Advanced Breast Cancer during Mohs Paste Treatment]Hitomi Kubota, Kenichi Sakurai, Shigeru Fujisaki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[Long-Term Capecitabine Therapy Was Successful for Locally Advanced Breast Cancer Patient - Report of a Case]Keita Adachi, Kenichi Sakurai, Shuhei Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Indoleamine 2,3-Dioxygenase Activity during Fulvestrant Therapy for Aromatase Inhibitor Resistant Metastatic Breast Cancer]Kenichi Sakurai, Shigeru Fujisaki, Hitomi Kubota, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 26, 2017
[Two Cases in Which Eribulin Mesylate Was Effective for Taxane-Resistant Advanced Breast Cancer]Keita Adachi, Shuhei Suzuki, Hitomi Kubota, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 4, 2018
[Breast Cancer Occurring in the Axillary Area - A Case Report]Keita Adachi, Kenichi Sakurai, Shuhei Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 2, 2018
[Treatment Experience of Palbociclib as a New Checkpoint Inhibitor]Kenichi Sakurai, Shigeru Fujisaki, Hitomi Kubota, et al.Pageof 6